GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (CHIX:DIAm) » Definitions » Cyclically Adjusted PB Ratio

Diasorin SpA (CHIX:DIAM) Cyclically Adjusted PB Ratio : 4.33 (As of Jun. 23, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Diasorin SpA Cyclically Adjusted PB Ratio?

As of today (2025-06-23), Diasorin SpA's current share price is €93.00. Diasorin SpA's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €21.47. Diasorin SpA's Cyclically Adjusted PB Ratio for today is 4.33.

The historical rank and industry rank for Diasorin SpA's Cyclically Adjusted PB Ratio or its related term are showing as below:

CHIX:DIAm' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.19   Med: 9.93   Max: 20.36
Current: 4.38

During the past years, Diasorin SpA's highest Cyclically Adjusted PB Ratio was 20.36. The lowest was 4.19. And the median was 9.93.

CHIX:DIAm's Cyclically Adjusted PB Ratio is ranked worse than
79.71% of 138 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.835 vs CHIX:DIAm: 4.38

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Diasorin SpA's adjusted book value per share data for the three months ended in Mar. 2025 was €31.283. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €21.47 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Diasorin SpA Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Diasorin SpA's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Cyclically Adjusted PB Ratio Chart

Diasorin SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.79 13.09 7.90 5.00 4.79

Diasorin SpA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.65 4.68 - 4.79 4.25

Competitive Comparison of Diasorin SpA's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Diasorin SpA's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Cyclically Adjusted PB Ratio falls into.


;
;

Diasorin SpA Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Diasorin SpA's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=93.00/21.47
=4.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diasorin SpA's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Diasorin SpA's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=31.283/122.5000*122.5000
=31.283

Current CPI (Mar. 2025) = 122.5000.

Diasorin SpA Quarterly Data

Book Value per Share CPI Adj_Book
201506 9.677 100.279 11.821
201509 10.054 100.000 12.316
201512 10.674 99.814 13.100
201603 10.989 99.600 13.516
201606 10.749 99.900 13.181
201609 0.000 100.100 0.000
201612 12.104 100.300 14.783
201703 12.654 101.000 15.348
201706 12.088 101.100 14.647
201709 12.617 101.200 15.273
201712 13.383 101.200 16.200
201803 13.918 101.800 16.748
201806 11.421 102.400 13.663
201809 12.045 102.600 14.381
201812 12.894 102.300 15.440
201903 13.807 102.800 16.453
201906 13.654 103.100 16.223
201909 14.798 102.900 17.617
201912 15.488 102.800 18.456
202003 16.332 102.900 19.443
202006 16.194 102.900 19.279
202009 16.538 102.300 19.804
202012 17.433 102.600 20.814
202103 19.392 103.700 22.908
202106 20.738 104.200 24.380
202109 22.607 104.900 26.400
202112 24.958 106.600 28.681
202203 27.508 110.400 30.523
202206 28.497 112.500 31.030
202209 30.292 114.200 32.494
202212 28.387 119.000 29.222
202303 28.522 118.800 29.410
202306 28.053 119.700 28.709
202309 29.109 120.300 29.641
202312 28.835 119.700 29.510
202403 30.332 120.200 30.912
202406 30.310 120.700 30.762
202409 0.000 121.200 0.000
202412 33.417 121.200 33.775
202503 31.283 122.500 31.283

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Diasorin SpA  (CHIX:DIAm) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Diasorin SpA Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Diasorin SpA Business Description

Traded in Other Exchanges
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines